Aehr Test Systems
AEHR
$84.42
-12.11%
Aehr Test Systems designs, manufactures, and sells advanced test and burn-in systems for logic, optical, and memory integrated circuits, operating within the semiconductor equipment industry. The company is a niche player specializing in critical quality and reliability testing, particularly for the high-growth Automotive and Mobility markets. The current investor narrative is overwhelmingly driven by its perceived role in the AI infrastructure build-out, with recent news highlighting massive new bookings and a stock surge tied to booming AI data center spending and demand for specialized testing equipment for power components.…
AEHR
Aehr Test Systems
$84.42
Related headlines
Investment Opinion: Should I buy AEHR Today?
Rating: Hold. The core thesis is that AEHR is a high-risk, high-potential story stock where the explosive growth narrative is starkly disconnected from deteriorating current fundamentals, creating a 'show me' situation that warrants caution.
Supporting Evidence: The stock's valuation is speculative, with a negative P/E (-73.38) and a sky-high forward EV/Sales of 65.57, pricing in monumental growth. While analyst revenue estimates of $196.1M suggest a massive ramp, recent quarterly revenue of $9.88M is down -26.53% YoY, and profitability is worsening (net income of -$3.23M). The balance sheet is a positive with a 5.68 current ratio and 0.088 D/E, providing a runway, but cash flow is deeply negative at -$11.91M TTM. The technical picture shows extreme volatility (beta 3.183) and a -10.13% pullback over the past month, indicating momentum may be stalling.
Risks & Conditions: The two biggest risks are 1) continued failure to translate bookings into growing, profitable sales, and 2) a sustained cash burn leading to dilution. This Hold rating would upgrade to a Buy if the company demonstrates consecutive quarters of revenue acceleration above 50% YoY and a clear path to positive operating cash flow. It would downgrade to a Sell if quarterly revenue fails to grow sequentially in the next report or if cash burn accelerates further. Relative to its own history, the stock is fairly valued at a PS of 4.79, but relative to the growth required, it remains overvalued until proof emerges.
Sign up to view all
AEHR 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The investment case is binary: either AEHR becomes a hyper-growth story justifying its multiple, or it fails to execute and faces a precipitous fall. The strong balance sheet and powerful market narrative provide a floor and a catalyst for rallies, but the deteriorating fundamentals and cash burn create a high probability of volatility and disappointment. The stance would upgrade to bullish on evidence of sustained revenue acceleration above 50% QoQ and margin stabilization. It would turn bearish if the next quarter shows no sequential revenue growth or an acceleration in cash burn.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aehr Test Systems's 12-month outlook, with a consensus price target around $109.75 and implied upside of +30.0% versus the current price.
Average Target
$109.75
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$68 - $110
Analyst target range
Analyst coverage for Aehr Test Systems appears minimal, with data indicating only one analyst providing estimates for revenue and EPS, and no consensus price target or recommendation distribution provided in the dataset. This constitutes insufficient analyst coverage, which is typical for small-cap stocks like AEHR (market cap ~$282 million) and can lead to higher volatility and less efficient price discovery. The lack of a broad analyst consensus means investor sentiment is likely driven more by news flow, technical trading, and speculative narratives around AI and semiconductor capex cycles rather than institutional research, increasing the stock's risk profile.
Bulls vs Bears: AEHR Investment Factors
The bull and bear cases for AEHR present a classic growth story versus fundamentals tension. The bull case is powered by a transformative narrative around AI-driven demand, evidenced by massive new bookings and a stock that has risen over 746% in a year, supported by a strong, debt-free balance sheet. The bear case is grounded in harsh financial reality: declining revenue, deepening losses, severe cash burn, and a speculative valuation multiple. Currently, the bear side has stronger evidence from the reported financials, which show clear deterioration. The single most important tension in the investment debate is whether the promised $37.2M+ in new bookings and the analyst-projected ~$196M revenue can be converted into sustained, profitable growth fast enough to justify the current valuation and offset the ongoing cash burn. The stock's fate hinges entirely on this execution bridge between narrative and numbers.
Bullish
- Massive AI-Driven Order Momentum: Recent news highlights a massive $37.2 million in new bookings, directly tied to booming AI data center spending and demand for specialized testing equipment for power components. This validates the company's strategic positioning in a high-growth niche and suggests a significant future revenue ramp, which is critical given the current quarterly revenue of only $9.88 million.
- Strong Balance Sheet with Minimal Debt: The company has a fortress balance sheet with a current ratio of 5.68 and a very low debt-to-equity ratio of 0.088. This provides significant financial flexibility and resilience, allowing it to fund operations and invest in growth without the pressure of high leverage, especially important as it currently burns cash.
- Extreme Price Momentum and Market Narrative: The stock has delivered a staggering +746.53% 1-year return, driven by a powerful market narrative linking it to AI infrastructure build-out. This momentum reflects high investor conviction in the long-term growth story, even if fundamentals are currently weak, and can attract further capital.
- Valuation Reset to Lower Historical PS: The current Price-to-Sales (PS) ratio of 4.79 is near the bottom of its own recent historical band, which has ranged from ~20 to above 69. This could indicate a valuation reset that provides a more attractive entry point if the anticipated sales growth from new bookings materializes, compared to its recent peak multiples.
Bearish
- Severe Fundamental Deterioration: Recent quarterly revenue declined -26.53% YoY to $9.88M, while net income worsened to -$3.23M and gross margin compressed to 25.75% from 33.90% in the prior quarter. This demonstrates significant near-term operational weakness and profitability challenges, starkly contrasting with the bullish narrative.
- Unsustainable Cash Burn: The company is burning cash at an alarming rate, with trailing twelve-month free cash flow of -$11.91M and latest quarterly operating cash flow of -$1.39M. With a market cap of ~$282M, this burn rate is not sustainable long-term without dilutive financing or a rapid turnaround in profitability.
- Extreme Volatility and High Beta: The stock's beta of 3.183 means it is over three times more volatile than the market. This is evidenced by a -10.13% 1-month pullback amidst a massive yearly rally, indicating high risk and susceptibility to sharp corrections, making it unsuitable for risk-averse investors.
- Speculative Valuation with Negative Earnings: The company is unprofitable with a trailing P/E of -73.38 and a forward EV/Sales of 65.57. This valuation is entirely speculative, predicated on future growth that has yet to materialize in the financials, leaving the stock highly vulnerable to multiple compression if execution falters.
AEHR Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +746.53%. As of the latest close at $98.79, the price is trading at approximately 78% of its 52-week range ($11.76 to $126.62), positioning it near recent highs which reflects strong momentum but also suggests potential for overextension after such a massive run. Recent short-term momentum, however, shows signs of volatility and potential consolidation; the 1-month price change is -10.13%, which diverges sharply from the longer-term bullish trend and indicates a significant pullback or profit-taking phase. This divergence is further highlighted by the stock's extreme beta of 3.183, meaning it is over three times more volatile than the broader market, which amplifies both gains and corrections. Key technical levels are clearly defined by the 52-week high of $126.62 as major resistance and the 52-week low of $11.76 as distant support. A breakout above the $126.62 resistance would signal a resumption of the powerful uptrend, while a sustained breakdown below recent lows could indicate a deeper correction; the high beta underscores that any moves will be magnified, requiring careful risk management.
Beta
3.18
3.18x market volatility
Max Drawdown
-42.3%
Largest decline past year
52-Week Range
$12-$127
Price range past year
Annual Return
+498.3%
Cumulative gain past year
| Period | AEHR Return | S&P 500 |
|---|---|---|
| 1m | -9.8% | -1.7% |
| 3m | +90.5% | +13.7% |
| 6m | +281.0% | +9.2% |
| 1y | +498.3% | +20.7% |
| ytd | +281.0% | +9.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AEHR Fundamental Analysis
Revenue growth is currently negative and volatile, with the most recent quarterly revenue at $9.88 million representing a -26.53% year-over-year decline, indicating a significant near-term contraction in sales. Segment data shows Systems revenue of $6.76 million is the primary driver, but overall revenue trajectory has been inconsistent, with the prior quarter (Q1 2026) at $10.97 million, suggesting lumpy order patterns rather than steady growth. The company is unprofitable, with a net income of -$3.23 million and a gross margin of 25.75% in the latest quarter, which is low for a technology equipment company. Profitability has deteriorated sequentially, as the prior quarter showed a net income of -$2.08 million and a higher gross margin of 33.90%, indicating margin compression and a move away from profitability. The balance sheet shows a strong liquidity position with a current ratio of 5.68 and a low debt-to-equity ratio of 0.088, suggesting minimal financial leverage risk. However, cash flow is a major concern, with trailing twelve-month free cash flow deeply negative at -$11.91 million and the latest quarterly operating cash flow at -$1.39 million, indicating the company is burning cash and dependent on its balance sheet or external financing to fund operations.
Quarterly Revenue
$9884000.0B
2025-11
Revenue YoY Growth
-0.26%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$-11907000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AEHR Overvalued?
Given the negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 4.79, while the forward-looking metric, EV-to-Sales, is significantly higher at 65.57, indicating the market is pricing in a substantial future revenue ramp relative to the current depressed sales base. Compared to industry averages, data is not available in the provided dataset for a direct sector PS or EV/Sales comparison, making a quantified premium/discount assessment impossible; the high forward EV/Sales suggests the market anticipates explosive growth, but without a peer benchmark, the justification for this multiple remains speculative. Historically, the stock's own PS ratio has been extremely volatile, ranging from recent highs above 69.83 (Q2 2026) to lows around 20.19 (Q4 2025); the current PS of 4.79 is near the bottom of its own recent historical band, which could signal a value opportunity if the sales growth narrative materializes, or it may reflect a market reassessment of growth prospects following the recent sharp price correction.
PE
-73.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -111x~168x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-296.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AEHR faces severe financial risks centered on its deteriorating profitability and unsustainable cash consumption. The company reported a net loss of -$3.23M last quarter on revenue of $9.88M, with gross margin collapsing to 25.75% from 33.90% sequentially. More critically, trailing twelve-month free cash flow is -$11.91M, indicating the company is funding operations by drawing down its balance sheet. With only 136 employees and a niche market, revenue concentration risk is high; the business is dependent on a few large orders in the volatile semiconductor equipment cycle, making quarterly results extremely lumpy and unpredictable, as seen in the -26.53% YoY revenue decline.
Market & Competitive Risks: The primary market risk is extreme valuation compression. The stock trades at a forward EV/Sales of 65.57, a multiple that demands flawless execution of hyper-growth. Any stumble in converting bookings to revenue, a slowdown in AI infrastructure spending, or a broader sector rotation away from speculative tech could trigger a severe derating. The stock's beta of 3.183 confirms its hyper-sensitivity to market sentiment. Competitive risks include larger, better-capitalized semiconductor test equipment players potentially encroaching on its niche, though its specialization in burn-in for automotive and AI power components provides some moat.
Worst-Case Scenario: The worst-case scenario involves a failure to convert the large bookings pipeline into profitable revenue growth, coupled with continued cash burn. This could lead to a liquidity crisis requiring dilutive equity financing, a loss of investor confidence, and a rapid unwinding of the speculative premium. The stock could realistically re-test its 52-week low of $11.76, representing a downside of approximately -88% from the current price of $98.79. A more measured bear case, aligning with a return to its pre-AI-narrative valuation levels, could see a decline of -50% to -70%.
FAQ
The key risks are, in order of severity: 1) Execution Risk: Failure to convert the $37.2M+ bookings into sustained revenue and profit growth, as evidenced by the recent -26.53% YoY sales decline. 2) Financial Risk: Unsustainable cash burn (-$11.91M TTM FCF) that could lead to dilution or liquidity issues despite a strong balance sheet. 3) Valuation Risk: The extreme forward EV/Sales of 65.57 leaves the stock vulnerable to severe multiple compression if growth disappoints. 4) Volatility Risk: A beta of 3.183 means the stock is over three times more volatile than the market, leading to wild price swings, as seen in the -10% monthly drop amidst a massive yearly rally.
The 12-month forecast for AEHR is highly bifurcated, with a wide range of outcomes. Our base case (50% probability) sees the stock trading between $70 and $110 as it demonstrates choppy progress on its growth path. The bull case (25% probability), driven by successful execution of its AI order book, could propel the stock to $126-$180. The bear case (25% probability), triggered by execution failure and cash burn, could see a collapse toward the $12-$50 range. The most likely scenario is the base case of high volatility within a range, as the market awaits concrete financial proof of the growth narrative. The key assumption is that revenue begins to inflect positively but falls short of the most optimistic targets.
AEHR's valuation is speculative and context-dependent. Based on current fundamentals—negative earnings and a PS ratio of 4.79—it appears fairly valued relative to its own recent historical PS range (20-69). However, the forward-looking EV/Sales multiple of 65.57 is extremely high, indicating the market is pricing in explosive future sales growth that has not yet materialized. Compared to industry peers, data is unavailable, but such a multiple implies the market expects revenue to grow nearly 20x from its current quarterly run-rate. Therefore, it is overvalued based on current financials but could be undervalued if the projected ~$196M in annual revenue is achieved.
AEHR is a high-risk, high-potential stock that is only suitable for aggressive investors with a high tolerance for volatility. The bullish case, driven by massive AI-related bookings and a 746% yearly return, is compelling but speculative. The bearish case, supported by a -26.53% YoY revenue decline and negative cash flow, is grounded in hard data. With a forward EV/Sales of 65.57, the valuation demands flawless execution. It could be a good buy for speculative capital if you believe the company can rapidly convert its backlog into profitable growth, but it is a poor choice for conservative or income-oriented investors.
AEHR is unsuitable for short-term trading for most investors due to its extreme volatility (beta 3.183) and lack of near-term earnings visibility. It is a speculative long-term investment for those betting on the multi-year adoption of its testing technology in AI and automotive markets. The investment thesis requires a 3-5 year horizon to allow for the company to scale revenue, achieve profitability, and generate positive cash flow. Given the binary outcome potential, investors must be prepared to hold through significant drawdowns. There is no dividend, and the stock's performance will be entirely driven by growth execution, making it purely a capital appreciation story for patient, risk-seeking capital.